Sirona Biochem Corp V.SBM

New patent

[Turtle4]

https://patentscope.wipo.int/search/de/detail.jsf?docId=US372514764&_cid=P20-L7F7FI-34676-1 Patent granted. So the anti aging study can begin now?

[Pandora]

They do not have the "patent" yet -- they just received the "Publication Number" so it is a ways off yet: Assignment abstract of title for Application 17627347 Invention title/Inventor Glycopeptides Increasing Lipid Synthesis Graldine Deliencourt-Godefroy, Jocelyne Legoedec Patent None

[biorun]

This may be part of IP protection- the anti-aging patents were filed at least a year or two ago..

[Pandora]

Excerpts from the patent documentation: Abstract The present invention relates to a glycopeptide of the following formula I: or a tautomer, a stereoisomer or a mixture of stereoisomers thereof in any proportions, in particular a mixture of enantiomers, and particularly a racemate mixture, and/or a physiologically acceptable salt and/or solvate thereof, in which:--n represents an integer from

[Pandora]

Sounds like it may become a competitor to Botox??

[Tickel1st]

This post has been removed in accordance with Community Policy

[Pandora]

If you read the full patent document that may even be buried in there. They are long, wordy and complex.  :-))

[biorun]

If Abbvie picks this up too, global rights, or outright purchase,  it could get very lucrative here.

[hcdtrading]

Bio give it a break man, it could be very lucrative huh?  Is pumping this stock regardless of how terrible it is your full time job? 24/7 365 days a year we can depend on bio to pump SBM.  The company sucks! you know that and every investor knows it. enough already.  What do you rate Howard as CEO again? you keep avoiding this because you work for SBM and cant say what you rate

[biorun]

oh brother, you again. lmfao.  However, every time you show up, its time for another run, which does make me happy. poking at the company to shake 5000 shares from the tree. for Howard, I am sure he is a great doctor, but replacing him with a CEO who has professional business development experience within the big pharma world would certainly be a good step in the right direction. he gets